Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,01 USD | +0,33% | -3,15% | -13,14% |
Omzet 2024 * | 2,39 mln. 2,24 mln. | Omzet 2025 * | 9,5 mln. 8,91 mln. | Marktkapitalisatie | 3,02 mld. 2,83 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -220 mln. -206 mln. | Nettowinst (verlies) 2025 * | -260 mln. -244 mln. | EV/omzet 2024 * | 1.027 x |
Nettoliquiditeiten 2024 * | 560 mln. 526 mln. | Nettoliquiditeiten 2025 * | 507 mln. 476 mln. | EV/omzet 2025 * | 264 x |
K/w-verhouding 2024 * |
-13,5
x | K/w-verhouding 2025 * |
-12
x | Werknemers | 255 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,16% |
Recentste transcriptie over Xenon Pharmaceuticals Inc.
1 dag | +0,33% | ||
1 week | -3,15% | ||
Lopende maand | -7,06% | ||
1 maand | -9,07% | ||
3 maanden | -11,48% | ||
6 maanden | +20,37% | ||
Lopend jaar | -13,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21-10-13 |
Simon Pimstone
FOU | Founder | 56 | 05-11-96 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 05-11-20 |
Mohammad Azab
BRD | Director/Board Member | 68 | 01-10-03 |
Justin Gover
BRD | Director/Board Member | 53 | 08-08-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.96% | 16 M€ | -7,93% | ||
0.22% | 0 M€ | 0,00% | - | |
0.22% | 0 M€ | 0,00% | - | |
0.20% | 12 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 40,01 | +0,33% | 395 140 |
19-04-24 | 39,88 | -1,07% | 362 875 |
18-04-24 | 40,31 | -3,17% | 324 121 |
17-04-24 | 41,63 | +0,34% | 393 800 |
16-04-24 | 41,49 | +0,44% | 409 168 |
uitgestelde koers Nasdaq, 22 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-13,14% | 3,02 mld. | |
+2,49% | 96,73 mld. | |
-0,32% | 21,31 mld. | |
-16,61% | 21,21 mld. | |
-5,15% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-27,40% | 13,68 mld. | |
+1,44% | 13,44 mld. | |
+21,29% | 10,98 mld. | |
-21,79% | 8,56 mld. |